drugset / Trial / NCT01442610

Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease

NCT01442610

RandomizedParallel-groupQuadruple-blindTreatment

Summary

As the MAO-B inhibitor rasagiline is able to improve motor skills it might have positive effects on sleep disruption by reducing nocturnal akinesia. As it was reported to cause only minor sleep disruption in PD Patients, it might be able to improve sleep architecture. The investigators thus study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and PDSS-2. Secondary measures are other sleep variables measured by PSG, sleep quality and daytime sleepiness assessed by standardized scales as well as cognitive function, depression and QoL index.

Timeline

Start
2011-10
Primary completion
2015-03
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rasagiline Small molecule 1 mg